FDA, Blood Pressure
Digest more
The U.S. Food and Drug Administration recalled more than 140,000 bottles of a common statin medication. Is your medication one of them?
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.
The U.S. Food and Drug Administration (“FDA”) announced the launch of its “Green List” initiative designed to protect consumers from illegally imported GLP-1 drug ingredients—such as semaglutide and tirzepatide—on September 5, 2025. According ...
CT Insider on MSN
FDA expands recall on cinnamon products due to lead hazard
This article originally published at FDA expands recall on cinnamon products due to lead hazard. Symptoms of the condition vary from person to person, but there are a few feelings and habits to note.
April 17, 2012 — The US Food and Drug Administration (FDA) today issued its latest quarterly list of drugs to monitor after having identified potential signs of serious risks or new safety information in the agency's Adverse Event Reporting System (AERS ...
Additional ground cinnamon products were the subject of an Oct. 30 recall notice from the FDA. Affected products contained "elevated" levels of lead.